Cargando…
Experimental treatment of stroke in spontaneously hypertensive rats by CD34(+ )and CD34(-) cord blood cells
Human umbilical cord blood as a source of stem cells has recently been reported in experimental treatment of cerebral disorders. However, little is known about the nature of cells and cellular mechanisms leading to neurofunctional improvement. Here we investigated the potential of separated CD34(+)...
Autores principales: | Boltze, Johannes, Kowalski, Ina, Geiger, Kathrin, Reich, Doreen, Gunther, Albrecht, Buhrle, Christian, Egger, Dietmar, Kamprad, Manja, Emmrich, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
German Medical Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703252/ https://www.ncbi.nlm.nih.gov/pubmed/19675726 |
Ejemplares similares
-
Neuronal hypoxia in vitro: Investigation of therapeutic principles of HUCB-MNC and CD133(+ )stem cells
por: Reich, Doreen M, et al.
Publicado: (2008) -
Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro
por: Hau, Susann, et al.
Publicado: (2008) -
Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021) -
CD34(+) stem cells from umbilical cord blood
por: Pafumi, Carlo, et al.
Publicado: (2011) -
Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)